The drug industry began ramping up its lobbying efforts in 2003, when Medicare Part D began, and now is targeting Democrats. CQ Politics reports: “The industry is increasingly employing Democratic lobbyists with ties to the Obama administration and congressional leaders such as Sen. Max Baucus, D-Mont., chairman of the Senate Finance Committee.
Read More…
Related Posts
- At Finance Committee, Fireworks Surround Efforts To Add Drug Discount, Eliminate Individual Mandate
- Democrats, Republicans, Health Industry ‘Players’ Consider Compromises In Health Debate, According To Journal Editorial, Times
- House Democrats Introduce Legislation That Would Allow Medicare To Offer Prescription Drug Plans That Compete With Private Plans
- Obama Budget Request Increases International Global Health Funding
- Ohio Changes Medicaid Drug Program, N.C. Weighs Cuts In Medicaid Personal Care Services
- Lobbyists Continue Efforts To Influence Health Overhaul
- Difficult Issues Will Remain Even If Senate Democrats Pass Health Bill
- Democrats’ Ideas To Expand Medicare Raise The Hackles Of Doctors, Hospitals, Insurers
- New York Cuts Drug Reimbursements, States Trim Tobacco Prevention Funding
- Senate’s Efforts On Health Care Being Slowed By Other Issues
- AARP, Key Retirees’ Lobby, To Endorse Democrats’ Health Bill
- Some Senate Democrats Help Republicans Defeat $247 Billion Medicare Payment ‘Doctor Fix’
- Rural Doctors, Administrators Push For Health Reform To Include Safeguards Against Rx Drug Abuse
- CMS Proposes New Rules For Medicare Advantage And Prescription Drug Plans To Better Serve Beneficiaries
- GOP Continues Health Reform Opposition, Quotes Concerned Democrats
Tags: democrats, drug, easing, efforts, increases, industry, lobbying, targets
This entry was posted
on Friday, July 3rd, 2009 at 8:07 pm and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
